🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Metformin Use on Weight Loss in Obese, Non-diabetic People (MOWRI)

RecruitingPhase 3Ages 20 Years - 59 YearsAllUniversity Of Nigeria Teaching Hospital
NCT07297290 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Obesity is a chronic disease of global public health concern, contributing to cardiovascular disease, type 2 diabetes and certain cancers. Currently approved anti-obesity drugs and surgery are expensive and not readily available in Nigeria. Metformin, approved for type 2 diabetes, has been shown to promote weight loss among obese patients in high income countries. However, metformin's effects have not yet been demonstrated in Black African populations, which may have different genetic and environmental predispositions to obesity and to the effect of metformin. This blinded, placebo-controlled, randomized trial is determining the effect of metformin on weight loss, cardiovascular disease risk and insulin resistance in Black Nigerians.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * • Obesity (defined as body mass index ≥ 30kg/m2), * Fasting plasma glucose (\<7.0mmol/L) * No medical treatment for weight control in the previous 12 months * No participation in a current clinical trial Exclusion Criteria: * • Obesity (defined as body mass index ≥ 30kg/m2), * Fasting plasma glucose (\<7.0mmol/L) * No medical treatment for weight control in the previous 12 months * No participation in a current clinical trial
💊

What it tests

  • Metformin
  • Placebo
📍

Where

2 sites
Pathology Facility
Enugu, Nigeria
University of Nigeria Teaching Hospital
Enugu, Nigeria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy